EIB-Informationen 3-2001 (Nr. 109)

The study identifies the main barriers to scaling innovation in the EU bio-based industry sector, providing specific recommendations to address bottlenecks in bringing new technologies to the market.

These procedures set out how the EIB assesses and takes account of environmental, climate and social impacts, risks and opportunities in its financing throughout the project cycle.

The strategic orientation is a new compass for EIB Global’s investments outside the European Union, with the goal of strengthening the contribution of the EIB Group to Europe’s position in a changing world.